Skip to main content
NCBI home page
British Journal of Sports Medicine logoLink to British Journal of Sports Medicine
. 2003 Aug;37(4):315–320. doi: 10.1136/bjsm.37.4.315

Decreased maximal aerobic capacity with use of a triphasic oral contraceptive in highly active women: a randomised controlled trial

C Lebrun 1, M Petit 1, D McKenzie 1, J Taunton 1, J Prior 1
PMCID: PMC1724664  PMID: 12893716

Abstract

Background: Oral contraceptives are commonly used by women athletes. However, their effect on athletic performance is unclear.

Objectives: To examine the effects of a moderate dose, triphasic oral contraceptive on measures of athletic performance in highly trained women athletes.

Methods: This is a double blind, placebo controlled trial in 14 women with ovulatory menstrual cycles and maximal aerobic capacity (VO2MAX) ≥50 ml/kg/min. Four measures of athletic performance were tested: VO2MAX, anaerobic capacity (anaerobic speed test), aerobic endurance (time to fatigue at 90% of VO2MAX), and isokinetic strength (Cybex II dynamometer). Height, weight, and six skinfold measurements were also recorded. All these observational tests were completed during both the follicular and mid-luteal phases of an ovulatory menstrual cycle. Cycle phases were confirmed by assaying plasma oestradiol and progesterone. Participants were subsequently randomly assigned to either a tricyclic oral contraceptive or placebo and retested in identical fashion (oral contraceptive phase).

Results: Absolute and relative changes in VO2MAX from follicular to oral contraceptive phase decreased in the oral contraceptive group by 4.7%, whereas the placebo group showed a slight increase (+1.5%) over the same time period. Two of the women taking oral contraceptive had decreases of 4 and 9 ml/kg/min. In contrast, most women in the placebo group improved or maintained VO2MAX. There was also a significant increase in the sum of skinfolds in women taking oral contraceptive compared with those taking placebo (p<0.01). There were no significant changes in other physiological variables (maximum ventilation, heart rate, respiratory exchange ratio, packed cell volume) or measures of performance (anaerobic speed test, aerobic endurance, isokinetic strength) as a function of oral contraceptive treatment.

Conclusions: The decrease in VO2MAX that occurs when oral contraceptive is taken may influence elite sporting performance in some women. Further studies are required to determine the mechanisms of this change.

Full Text

The Full Text of this article is available as a PDF (189.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abraham G. E., Maroulis G. B., Marshall J. R. Evaluation of ovulation and corpus luteum function using measurements of plasma progesterone. Obstet Gynecol. 1974 Oct;44(4):522–525. [PubMed] [Google Scholar]
  2. Ashley C. D., Kramer M. L., Bishop P. Estrogen and substrate metabolism: a review of contradictory research. Sports Med. 2000 Apr;29(4):221–227. doi: 10.2165/00007256-200029040-00001. [DOI] [PubMed] [Google Scholar]
  3. Beck P. Contraceptive steroids: modifications of carbohydrate and lipid metabolism. Metabolism. 1973 Jun;22(6):841–855. doi: 10.1016/0026-0495(73)90056-5. [DOI] [PubMed] [Google Scholar]
  4. Bonekat H. W., Dombovy M. L., Staats B. A. Progesterone-induced changes in exercise performance and ventilatory response. Med Sci Sports Exerc. 1987 Apr;19(2):118–123. [PubMed] [Google Scholar]
  5. Bonen A., Haynes F. W., Graham T. E. Substrate and hormonal responses to exercise in women using oral contraceptives. J Appl Physiol (1985) 1991 May;70(5):1917–1927. doi: 10.1152/jappl.1991.70.5.1917. [DOI] [PubMed] [Google Scholar]
  6. Bryner R. W., Toffle R. C., Ullrich I. H., Yeater R. A. Effect of low dose oral contraceptives on exercise performance. Br J Sports Med. 1996 Mar;30(1):36–40. doi: 10.1136/bjsm.30.1.36. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Casazza Gretchen A., Suh Sang-Hoon, Miller Benjamin F., Navazio Franco M., Brooks George A. Effects of oral contraceptives on peak exercise capacity. J Appl Physiol (1985) 2002 Nov;93(5):1698–1702. doi: 10.1152/japplphysiol.00622.2002. [DOI] [PubMed] [Google Scholar]
  8. Collins D. C. Sex hormone receptor binding, progestin selectivity, and the new oral contraceptives. Am J Obstet Gynecol. 1994 May;170(5 Pt 2):1508–1513. doi: 10.1016/s0002-9378(94)05012-x. [DOI] [PubMed] [Google Scholar]
  9. Coney P., Washenik K., Langley R. G., DiGiovanna J. J., Harrison D. D. Weight change and adverse event incidence with a low-dose oral contraceptive: two randomized, placebo-controlled trials. Contraception. 2001 Jun;63(6):297–302. doi: 10.1016/s0010-7824(01)00208-6. [DOI] [PubMed] [Google Scholar]
  10. Fortney S. M., Beckett W. S., Carpenter A. J., Davis J., Drew H., LaFrance N. D., Rock J. A., Tankersley C. G., Vroman N. B. Changes in plasma volume during bed rest: effects of menstrual cycle and estrogen administration. J Appl Physiol (1985) 1988 Aug;65(2):525–533. doi: 10.1152/jappl.1988.65.2.525. [DOI] [PubMed] [Google Scholar]
  11. Frankovich R. J., Lebrun C. M. Menstrual cycle, contraception, and performance. Clin Sports Med. 2000 Apr;19(2):251–271. doi: 10.1016/s0278-5919(05)70202-7. [DOI] [PubMed] [Google Scholar]
  12. Giacomoni M., Falgairette G. Decreased submaximal oxygen uptake during short duration oral contraceptive use: a randomized cross-over trial in premenopausal women. Ergonomics. 2000 Oct;43(10):1559–1570. doi: 10.1080/001401300750003989. [DOI] [PubMed] [Google Scholar]
  13. Greenblatt R. B. Oral contraceptives: the state of the art. Clin Ther. 1985;8(1):6–27. [PubMed] [Google Scholar]
  14. Huisveld I. A., Hospers J. E., Bernink M. J., Erich W. B., Bouma B. N. The effect of oral contraceptives and exercise on hemostatic and fibrinolytic mechanisms in trained women. Int J Sports Med. 1983 May;4(2):97–103. doi: 10.1055/s-2008-1026020. [DOI] [PubMed] [Google Scholar]
  15. Lebrun C. M. Effect of the different phases of the menstrual cycle and oral contraceptives on athletic performance. Sports Med. 1993 Dec;16(6):400–430. doi: 10.2165/00007256-199316060-00005. [DOI] [PubMed] [Google Scholar]
  16. Lebrun C. M., McKenzie D. C., Prior J. C., Taunton J. E. Effects of menstrual cycle phase on athletic performance. Med Sci Sports Exerc. 1995 Mar;27(3):437–444. [PubMed] [Google Scholar]
  17. Lynch N. J., Nimmo M. A. Effects of menstrual cycle phase and oral contraceptive use on intermittent exercise. Eur J Appl Physiol Occup Physiol. 1998 Nov;78(6):565–572. doi: 10.1007/s004210050462. [DOI] [PubMed] [Google Scholar]
  18. McNeill A. W., Mozingo E. Changes in the metabolic cost of standardized work associated with the use of an oral contraceptive. J Sports Med Phys Fitness. 1981 Sep;21(3):238–244. [PubMed] [Google Scholar]
  19. Notelovitz M., Zauner C., McKenzie L., Suggs Y., Fields C., Kitchens C. The effect of low-dose oral contraceptives on cardiorespiratory function, coagulation, and lipids in exercising young women: a preliminary report. Am J Obstet Gynecol. 1987 Mar;156(3):591–598. doi: 10.1016/0002-9378(87)90059-7. [DOI] [PubMed] [Google Scholar]
  20. Parkhouse W. S., McKenzie D. C., Hochachka P. W., Ovalle W. K. Buffering capacity of deproteinized human vastus lateralis muscle. J Appl Physiol (1985) 1985 Jan;58(1):14–17. doi: 10.1152/jappl.1985.58.1.14. [DOI] [PubMed] [Google Scholar]
  21. Petrofsky J. S., LeDonne D. M., Rinehart J. S., Lind A. R. Isometric strength and endurance during the menstrual cycle. Eur J Appl Physiol Occup Physiol. 1976 Mar 9;35(1):1–10. doi: 10.1007/BF00444652. [DOI] [PubMed] [Google Scholar]
  22. Rosenberg M. Weight change with oral contraceptive use and during the menstrual cycle. Results of daily measurements. Contraception. 1998 Dec;58(6):345–349. doi: 10.1016/s0010-7824(98)00127-9. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Sports Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES